Tobacco And Covid 19

“STOP” Analysis Of Controversial Study Reveals Important Flaws


Covid 19 e1588024542514 1024x684

After a recent study conducted in France suggested that smokers may be much less at risk of contracting Covid 19, French researchers announced their plans to test nicotine patches on coronavirus patients and frontline health workers.

The study, which stresses serious health risks of smoking, suggests that a substance in tobacco may lower the risk of getting coronavirus. This study prompted an alarming debate about whether smoking and nicotine products could reduce the risk of COVID-19.

And with potential misinformation reportedly spurring harmful behaviors, Stopping Tobacco Organizations and Products (STOP) researchers critically analyzed the study and found several concerning flaws that the public health community, governments and consumers should know about.

Access the STOP review.